SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Maier Wolfgang) srt2:(2020-2022)"

Sökning: WFRF:(Maier Wolfgang) > (2020-2022)

  • Resultat 1-9 av 9
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Kleineidam, Luca, et al. (författare)
  • Midlife occupational cognitive requirements protect cognitive function in old age by increasing cognitive reserve
  • 2022
  • Ingår i: Frontiers in Psychology. - : Frontiers Media SA. - 1664-1078. ; 13
  • Tidskriftsartikel (refereegranskat)abstract
    • Introduction: Several lifestyle factors promote protection against Alzheimer's disease (AD) throughout a person's lifespan. Although such protective effects have been described for occupational cognitive requirements (OCR) in midlife, it is currently unknown whether they are conveyed by brain maintenance (BM), brain reserve (BR), or cognitive reserve (CR) or a combination of them. Methods: We systematically derived hypotheses for these resilience concepts and tested them in the population-based AgeCoDe cohort and memory clinic-based AD high-risk DELCODE study. The OCR score (OCRS) was measured using job activities based on the O*NET occupational classification system. Four sets of analyses were conducted: (1) the interaction of OCR and APOE-ε4 with regard to cognitive decline (N = 2,369, AgeCoDe), (2) association with differentially shaped retrospective trajectories before the onset of dementia of the Alzheimer's type (DAT; N = 474, AgeCoDe), (3) cross-sectional interaction of the OCR and cerebrospinal fluid (CSF) AD biomarkers and brain structural measures regarding memory function (N = 873, DELCODE), and (4) cross-sectional and longitudinal association of OCR with CSF AD biomarkers and brain structural measures (N = 873, DELCODE). Results: Regarding (1), higher OCRS was associated with a reduced association of APOE-ε4 with cognitive decline (mean follow-up = 6.03 years), consistent with CR and BR. Regarding (2), high OCRS was associated with a later onset but subsequently stronger cognitive decline in individuals converting to DAT, consistent with CR. Regarding (3), higher OCRS was associated with a weaker association of the CSF Aβ42/40 ratio and hippocampal volume with memory function, consistent with CR. Regarding (4), OCR was not associated with the levels or changes in CSF AD biomarkers (mean follow-up = 2.61 years). We found a cross-sectional, age-independent association of OCRS with some MRI markers, but no association with 1-year-change. OCR was not associated with the intracranial volume. These results are not completely consistent with those of BR or BM. Discussion: Our results support the link between OCR and CR. Promoting and seeking complex and stimulating work conditions in midlife could therefore contribute to increased resistance to pathologies in old age and might complement prevention measures aimed at reducing pathology.
  •  
2.
  • Arndt, Daniel, et al. (författare)
  • The deal. II library, Version 9.3
  • 2021
  • Ingår i: Journal of Numerical Mathematics. - : Walter de Gruyter. - 1570-2820 .- 1569-3953. ; 29:3, s. 171-186
  • Tidskriftsartikel (refereegranskat)abstract
    • This paper provides an overview of the new features of the finite element library deal . II, version 9.3.
  •  
3.
  • Arndt, Daniel, et al. (författare)
  • The deal.II library, Version 9.4
  • 2022
  • Ingår i: Journal of Numerical Mathematics. - : Walter de Gruyter. - 1570-2820 .- 1569-3953. ; 30:3, s. 231-246
  • Tidskriftsartikel (refereegranskat)abstract
    • This paper provides an overview of the new features of the finite element library deal.II, version 9.4.
  •  
4.
  • Fischer, Katrin, et al. (författare)
  • The scaffold protein p62 regulates adaptive thermogenesis through ATF2 nuclear target activation
  • 2020
  • Ingår i: Nature Communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 11:1
  • Tidskriftsartikel (refereegranskat)abstract
    • During beta -adrenergic stimulation of brown adipose tissue (BAT), p38 phosphorylates the activating transcription factor 2 (ATF2) which then translocates to the nucleus to activate the expression of Ucp1 and Pgc-1 alpha. The mechanisms underlying ATF2 target activation are unknown. Here we demonstrate that p62 (Sqstm1) binds to ATF2 to orchestrate activation of the Ucp1 enhancer and Pgc-1 alpha promoter. P62(Delta 69-251) mice show reduced expression of Ucp1 and Pgc-1 alpha with impaired ATF2 genomic binding. Modulation of Ucp1 and Pgc-1 alpha expression through p62 regulation of ATF2 signaling is demonstrated in vitro and in vivo in p62(Delta 69-251) mice, global p62(-/-) and Ucp1-Cre p62(flx/flx) mice. BAT dysfunction resulting from p62 deficiency is manifest after birth and obesity subsequently develops despite normal food intake, intestinal nutrient absorption and locomotor activity. In summary, our data identify p62 as a master regulator of BAT function in that it controls the Ucp1 pathway through regulation of ATF2 genomic binding. Beta-adrenergic stimulation of brown adipose tissue leads to thermogenesis via the activating transcription factor 2 (ATF2) mediated expression of the thermogenic genes Ucp1 and Pgc-1 alpha. Here, the authors show that the scaffold protein p62 regulates brown adipose tissue function through modifying ATF2 genomic binding and subsequent Ucp1 and Pgc-1 alpha induction.
  •  
5.
  • Jansen, Iris E, et al. (författare)
  • Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers.
  • 2022
  • Ingår i: Acta neuropathologica. - : Springer Science and Business Media LLC. - 1432-0533 .- 0001-6322. ; 144:5, s. 821-842
  • Tidskriftsartikel (refereegranskat)abstract
    • Amyloid-beta 42 (Aβ42) and phosphorylated tau (pTau) levels in cerebrospinal fluid (CSF) reflect core features of the pathogenesis of Alzheimer's disease (AD) more directly than clinical diagnosis. Initiated by the European Alzheimer & Dementia Biobank (EADB), the largest collaborative effort on genetics underlying CSF biomarkers was established, including 31 cohorts with a total of 13,116 individuals (discovery n=8074; replication n=5042 individuals). Besides the APOE locus, novel associations with two other well-established AD risk loci were observed; CR1 was shown a locus for Aβ42 and BIN1 for pTau. GMNC and C16orf95 were further identified as loci for pTau, of which the latter is novel. Clustering methods exploring the influence of all known AD risk loci on the CSF protein levels, revealed 4 biological categories suggesting multiple Aβ42 and pTau related biological pathways involved in the etiology of AD. In functional follow-up analyses, GMNC and C16orf95 both associated with lateral ventricular volume, implying an overlap in genetic etiology for tau levels and brain ventricular volume.
  •  
6.
  • Jansen, Willemijn J, et al. (författare)
  • Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
  • 2022
  • Ingår i: JAMA neurology. - : American Medical Association (AMA). - 2168-6157 .- 2168-6149. ; 79:3, s. 228-243
  • Tidskriftsartikel (refereegranskat)abstract
    • One characteristic histopathological event in Alzheimer disease (AD) is cerebral amyloid aggregation, which can be detected by biomarkers in cerebrospinal fluid (CSF) and on positron emission tomography (PET) scans. Prevalence estimates of amyloid pathology are important for health care planning and clinical trial design.To estimate the prevalence of amyloid abnormality in persons with normal cognition, subjective cognitive decline, mild cognitive impairment, or clinical AD dementia and to examine the potential implications of cutoff methods, biomarker modality (CSF or PET), age, sex, APOE genotype, educational level, geographical region, and dementia severity for these estimates.This cross-sectional, individual-participant pooled study included participants from 85 Amyloid Biomarker Study cohorts. Data collection was performed from January 1, 2013, to December 31, 2020. Participants had normal cognition, subjective cognitive decline, mild cognitive impairment, or clinical AD dementia. Normal cognition and subjective cognitive decline were defined by normal scores on cognitive tests, with the presence of cognitive complaints defining subjective cognitive decline. Mild cognitive impairment and clinical AD dementia were diagnosed according to published criteria.Alzheimer disease biomarkers detected on PET or in CSF.Amyloid measurements were dichotomized as normal or abnormal using cohort-provided cutoffs for CSF or PET or by visual reading for PET. Adjusted data-driven cutoffs for abnormal amyloid were calculated using gaussian mixture modeling. Prevalence of amyloid abnormality was estimated according to age, sex, cognitive status, biomarker modality, APOE carrier status, educational level, geographical location, and dementia severity using generalized estimating equations.Among the 19097 participants (mean [SD] age, 69.1 [9.8] years; 10148 women [53.1%]) included, 10139 (53.1%) underwent an amyloid PET scan and 8958 (46.9%) had an amyloid CSF measurement. Using cohort-provided cutoffs, amyloid abnormality prevalences were similar to 2015 estimates for individuals without dementia and were similar across PET- and CSF-based estimates (24%; 95% CI, 21%-28%) in participants with normal cognition, 27% (95% CI, 21%-33%) in participants with subjective cognitive decline, and 51% (95% CI, 46%-56%) in participants with mild cognitive impairment, whereas for clinical AD dementia the estimates were higher for PET than CSF (87% vs 79%; mean difference, 8%; 95% CI, 0%-16%; P=.04). Gaussian mixture modeling-based cutoffs for amyloid measures on PET scans were similar to cohort-provided cutoffs and were not adjusted. Adjusted CSF cutoffs resulted in a 10% higher amyloid abnormality prevalence than PET-based estimates in persons with normal cognition (mean difference, 9%; 95% CI, 3%-15%; P=.004), subjective cognitive decline (9%; 95% CI, 3%-15%; P=.005), and mild cognitive impairment (10%; 95% CI, 3%-17%; P=.004), whereas the estimates were comparable in persons with clinical AD dementia (mean difference, 4%; 95% CI, -2% to 9%; P=.18).This study found that CSF-based estimates using adjusted data-driven cutoffs were up to 10% higher than PET-based estimates in people without dementia, whereas the results were similar among people with dementia. This finding suggests that preclinical and prodromal AD may be more prevalent than previously estimated, which has important implications for clinical trial recruitment strategies and health care planning policies.
  •  
7.
  • Kenny, Gavin, et al. (författare)
  • Timescales of impact melt sheet crystallization and the precise age of the Morokweng impact structure, South Africa
  • 2021
  • Ingår i: Earth and Planetary Science Letters. - : Elsevier BV. - 0012-821X .- 1385-013X. ; 567
  • Tidskriftsartikel (refereegranskat)abstract
    • Impact cratering was a fundamental geological process in the early Solar System and, thus, constraining the timescales over which large impact structures cool is critical to understanding the thermal evolution and habitability of early planetary crusts. Additionally, impacts can induce mass extinctions and establishing the precise timing of the largest impacts on Earth can shed light on their role in such events. Here we report a high-precision zircon U–Pb geochronology study of the Morokweng impact structure, South Africa, which appears to have a maximum present-day diameter of ∼80 km. Our work provides (i) constraints on the cooling of large impact melt sheets, and (ii) a high-precision age for one of Earth's largest impact events, previously proposed to have overlapped the ca. 145 Ma Jurassic–Cretaceous (J–K) boundary. High-precision U–Pb geochronology was performed on unshocked, melt-grown zircon from five samples from a borehole through approximately 800 m of preserved impact melt rock. Weighted mean 206Pb/238U dates for the upper four samples are indistinguishable, with relative uncertainties (internal errors) of better than 20 ka, whereas the lowermost sample is distinguishably younger than the others. Thermal modeling suggests that the four indistinguishable dates are consistent with in situ conductive cooling of melt at this location within 30 kyr of the impact. The younger date from the lowest sample cannot be explained by in situ conductive cooling in line with the overlying samples, but the date is within the ∼65 kyr timeframe for melt-present conditions in footwall rocks below the impact melt sheet that is indicated by our thermal model. The Morokweng impact event is here constrained to 146.06 ± 0.16 Ma (2σ; full external uncertainty), which precedes current estimates of the age of the J–K boundary by several million years.
  •  
8.
  • Maier, Hannes, et al. (författare)
  • Consensus Statement on Bone Conduction Devices and Active Middle Ear Implants in Conductive and Mixed Hearing Loss
  • 2022
  • Ingår i: Otology and Neurotology. - : Lippincott, Williams & Wilkins. - 1531-7129 .- 1537-4505. ; 43:5, s. 513-529
  • Tidskriftsartikel (refereegranskat)abstract
    • Nowadays, several options are available to treat patients with conductive or mixed hearing loss. Whenever surgical intervention is not possible or contra-indicated, and amplification by a conventional hearing device (e.g., behind-the-ear device) is not feasible, then implantable hearing devices are an indispensable next option. Implantable bone-conduction devices and middle-ear implants have advantages but also limitations concerning complexity/invasiveness of the surgery, medical complications, and effectiveness. To counsel the patient, the clinician should have a good overview of the options with regard to safety and reliability as well as unequivocal technical performance data. The present consensus document is the outcome of an extensive iterative process including ENT specialists, audiologists, health-policy scientists, and representatives/technicians of the main companies in this field. This document should provide a first framework for procedures and technical characterization to enhance effective communication between these stakeholders, improving health care.
  •  
9.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-9 av 9
Typ av publikation
tidskriftsartikel (9)
Typ av innehåll
refereegranskat (8)
övrigt vetenskapligt/konstnärligt (1)
Författare/redaktör
Maier, Wolfgang (5)
Blennow, Kaj, 1958 (3)
Zetterberg, Henrik, ... (3)
Boada, Mercè (3)
Skoog, Ingmar, 1954 (3)
Ramirez, Alfredo (3)
visa fler...
Scheltens, Philip (3)
Alcolea, Daniel (3)
Fortea, Juan (3)
Lleó, Alberto (3)
Wiltfang, Jens (3)
Heneka, Michael T. (3)
Peters, Oliver (3)
Wagner, Michael (3)
Jessen, Frank (3)
Sánchez-Juan, Pascua ... (3)
Tsolaki, Magda (2)
Vandenberghe, Rik (2)
Kern, Silke (2)
Zettergren, Anna, 19 ... (2)
van der Flier, Wiesj ... (2)
Teunissen, Charlotte ... (2)
Soininen, Hilkka (2)
Clarimon, Jordi (2)
Kornhuber, Johannes (2)
Grimmer, Timo (2)
Fladby, Tormod (2)
Engelborghs, Sebasti ... (2)
Arndt, Daniel (2)
Bangerth, Wolfgang (2)
Fehling, Marc (2)
Heister, Timo (2)
Heltai, Luca (2)
Kronbichler, Martin (2)
Maier, Matthias (2)
Munch, Peter (2)
Pelteret, Jean-Paul (2)
Turcksin, Bruno (2)
Wells, David (2)
Pastor, Pau (2)
Selnes, Per (2)
Buerger, Katharina (2)
Laske, Christoph (2)
Priller, Josef (2)
Schneider, Anja (2)
Teipel, Stefan (2)
Düzel, Emrah (2)
Hampel, Harald (2)
de Rojas, Itziar (2)
Moreno, Fermin (2)
visa färre...
Lärosäte
Göteborgs universitet (4)
Uppsala universitet (3)
Karolinska Institutet (2)
Umeå universitet (1)
Stockholms universitet (1)
Örebro universitet (1)
visa fler...
Linköpings universitet (1)
Lunds universitet (1)
Chalmers tekniska högskola (1)
Naturhistoriska riksmuseet (1)
visa färre...
Språk
Engelska (9)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (5)
Naturvetenskap (4)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy